Cotinine enhances the extinction of contextual fear memory and reduces anxiety after fear conditioning

Behavioural Brain Research

Volumn 228, Issue 2, 2012, Pages 284-293

  Zeitlin, Ross ^a   Patel, Sagar ^a   Solomon, Rosalynn ^a   Tran, John ^a   Weeber, Edwin J ^b,c   Echeverria, Valentina ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Corticosterone; ERK; Memory stability; Stress

Indexed keywords

CORTICOSTERONE; COTININE; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; ASSOCIATIVE MEMORY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG ACTIVITY; DRUG EFFECT; ELECTRIC SHOCK; ENZYME PHOSPHORYLATION; FATIGUE; FEAR; FEAR CONDITIONING; FEAR MEMORY; FREEZING; HIPPOCAMPUS; LOCOMOTION; MALE; MAZE TEST; MENTAL PERFORMANCE; MOTOR COORDINATION; MOUSE; NOCICEPTION; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORIMOTOR FUNCTION; SHORT TERM MEMORY; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BODY WEIGHT; BRAIN; CONDITIONING (PSYCHOLOGY); CORTICOSTERONE; COTININE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; EXPLORATORY BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEAR; FREEZING REACTION, CATALEPTIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; NOCICEPTION; ROTAROD PERFORMANCE TEST; TIME FACTORS;

EID: 84856211951     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.023     Document Type: Article

References (52)

1. Martenyi F., Brown E.B., Caldwell C.D. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol 2007, 27:166-170.
2. Yehuda R., Giller E.L., Southwick S.M., Lowy M.T., Mason J.W. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry 1991, 30:1031-1048.
3. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008, 33:56-72.
4. Nutt D.J. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry 2000, 61(Suppl. 5):24-29. discussion 30-2.
5. Shalev A.Y., Videlock E.J., Peleg T., Segman R., Pitman R.K., Yehuda R. Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part I: HPA axis responses. Int J Neuropsychopharmacol 2008, 11:365-372.
6. Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am 2002, 25:341-368. vii.
7. Meewisse M.L., Reitsma J.B., de Vries G.J., Gersons B.P., Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br J Psychiatry 2007, 191:387-392.
8. Stein D.J., Ipser J., McAnda N. Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines. CNS Spectrums 2009, 14:25-31.
9. Corchs F., Nutt D.J., Hood S., Bernik M. Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder. Biol Psychiatry 2009, 66(1):17-24.
10. Cohen H., Kotler M., Matar M., Kaplan Z. Normalization of heart rate variability in post-traumatic stress disorder patients following fluoxetine treatment: preliminary results. Isr Med Assoc J 2000, 2:296-301.
11. Riaza Bermudo-Soriano C., Perez-Rodriguez M.M., Vaquero-Lorenzo C., Baca-Garcia E. New perspectives in glutamate and anxiety. Pharmacol, Biochem Behav 2011, [Epub ahead of print].
12. Davis M., Barad M., Otto M., Southwick S. Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches. J Trauma Stress 2006, 19:571-581.
13. Cai W.H., Blundell J., Han J., Greene R.W., Powell C.M. Postreactivation glucocorticoids impair recall of established fear memory. J Neurosci 2006, 26:9560-9566.
14. Rasmusson A.M., Picciotto M.R., Krishnan-Sarin S. Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review. J Psychopharmacol 2006, 20:693-707.
15. Beckham J.C. Smoking and anxiety in combat veterans with chronic posttraumatic stress disorder: a review. J Psychoactive Drugs 1999, 31:103-110.
16. Nandi A., Galea S., Ahern J., Vlahov D. Probable cigarette dependence, PTSD, and depression after an urban disaster: results from a population survey of New York City residents 4 months after September 11, 2001. Psychiatry 2005, 68:299-310.
17. Weaver T.L., Etzel J.C. Smoking patterns, symptoms of PTSD and depression: preliminary findings from a sample of severely battered women. Addict Behav 2003, 28:1665-1679.
18. Leonard S., Adler L.E., Benhammou K., Berger R., Breese C.R., Drebing C., et al. Smoking and mental illness. Pharmacol Biochem Behav 2001, 70:561-570.
19. Echeverria V., Zeitlin R., Burgess S., Patel S., Barman A., Thakur G., et al. Cotinine reduces amyloid-β aggregation and improves memory in Alzheimer's disease mice. J Alzheimer's Dis 2011, 24:817-835.
20. Fuxe K., Everitt B.J., Hokfelt T. On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons. Pharmacol Biochem Behav 1979, 10:671-677.
21. Hatsukami D.K., Jensen J., Brauer L.H., Mooney M., Schulte S., Sofuoglu M., et al. Lack of effect of 5HT3 antagonist in mediating subjective and behavioral responses to cotinine. Pharmacol Biochem Behav 2003, 75:1-7.
22. Riah O., Courriere P., Dousset J.C., Todeschi N., Labat C. Nicotine is more efficient than cotinine at passing the blood-brain barrier in rats. Cell Mol Neurobiol 1998, 18:311-318.
23. Hatsukami D., Lexau B., Nelson D., Pentel P.R., Sofuoglu M., Goldman A. Effects of cotinine on cigarette self-administration. Psychopharmacology (Berl) 1998, 138:184-189.
24. Bowman E.R., Mc K.H. Studies on the metabolism of (-)-cotinine in the human. J Pharmacol Exp Ther 1962, 135:306-311.
25. Steckler T, Risbrough V. Pharmacological treatment of PTSD - Established and new approaches. Neuropharmacology, [Epub ahead of print].
26. Fischer A., Radulovic M., Schrick C., Sananbenesi F., Godovac-Zimmermann J., Radulovic J. Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior. Neurobiol Learn Mem 2007, 87:149-158.
27. Pibiri F., Nelson M., Guidotti A., Costa E., Pinna G. Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder. Proc Natl Acad Sci USA 2008, 105:5567-5572.
28. Vervliet B. Learning and memory in conditioned fear extinction: effects of d-cycloserine. Acta Psychol (Amst) 2008, 127:601-613.
29. Chhatwal J.P., Gutman A.R., Maguschak K.A., Bowser M.E., Yang Y., Davis M., et al. Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning. Neuropsychopharmacology 2009, 34:509-521.
30. Chen X., Garelick M.G., Wang H., Lil V., Athos J., Storm D.R. PI3 kinase signaling is required for retrieval and extinction of contextual memory. Nat Neurosci 2005, 8:925-931.
31. Bouton M.E., Westbrook R.F., Corcoran K.A., Maren S. Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol Psychiatry 2006, 60:352-360.
32. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 2001, 125:141-149.
33. Norcross M., Mathur P., Enoch A.J., Karlsson R.M., Brigman J.L., Cameron H.A., et al. Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6 J or BALB/cJ mice. Psychopharmacology (Berl) 2008, 200:413-424.
34. Arendash G.W., King D.L., Gordon M.N., Morgan D., Hatcher J.M., Hope C.E., et al. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 2001, 891:42-53.
35. Arendash G.W., Lewis J., Leighty R.E., McGowan E., Cracchiolo J.R., Hutton M., et al. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res 2004, 1012:29-41.
36. Jensen M.T., Mottin M.D., Cracchiolo J.R., Leighty R.E., Arendash G.W. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience 2005, 130:667-684.
37. Cannich A., Wotjak C.T., Kamprath K., Hermann H., Lutz B., Marsicano G. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. Learn Mem 2004, 11:625-632.
38. Feldner M.T., Babson K.A., Zvolensky M.J. Smoking, traumatic event exposure, and post-traumatic stress: a critical review of the empirical literature. Clin Psychol Rev 2007, 27:14-45.
39. Feldner M.T., Babson K.A., Zvolensky M.J., Vujanovic A.A., Lewis S.F., Gibson L.E., et al. Posttraumatic stress symptoms and smoking to reduce negative affect: an investigation of trauma-exposed daily smokers. Addict Behav 2007, 32:214-227.
40. Izquierdo I., Cammarota M., Vianna M.M., Bevilaqua L.R. The inhibition of acquired fear. Neurotox Res 2004, 6:175-188.
41. Mamiya N., Fukushima H., Suzuki A., Matsuyama Z., Homma S., Frankland P.W., et al. Brain region-specific gene expression activation required for reconsolidation and extinction of contextual fear memory. J Neurosci 2009, 29:402-413.
42. Buccafusco J.J., Terry A.V. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. Biochem Pharmacol 2009, 78:852-862.
43. Tian S., Gao J., Han L., Fu J., Li C., Li Z. Prior chronic nicotine impairs cued fear extinction but enhances contextual fear conditioning in rats. Neuroscience 2008, 153:935-943.
44. Ahi J., Radulovic J., Spiess J. The role of hippocampal signaling cascades in consolidation of fear memory. Behav Brain Res 2004, 149:17-31.
45. Szapiro G., Vianna M.R., McGaugh J.L., Medina J.H., Izquierdo I. The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear. Hippocampus 2003, 13:53-58.
46. Isosaka T., Kida S., Kohno T., Hattori K., Yuasa S. Hippocampal Fyn activity regulates extinction of contextual fear. Neuroreport 2009, 20:1461-1465.
47. Huh K.H., Guzman Y.F., Tronson N.C., Guedea A.L., Gao C., Radulovic J. Hippocampal Erk mechanisms linking prediction error to fear extinction: roles of shock expectancy and contextual aversive valence. Learn Mem 2009, 16:273-278.
48. Matsuda S., Matsuzawa D., Nakazawa K., Sutoh C., Ohtsuka H., Ishii D., et al. d-serine enhances extinction of auditory cued fear conditioning via ERK1/2 phosphorylation in mice. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(6):895-902.
49. Dhonnchadha B.A., Kantak K.M. Cognitive enhancers for facilitating drug cue extinction: insights from animal models. Pharmacol Biochem Behav 2011, 99(2):229-244.
50. Adamec R., Burton P., Blundell J., Murphy D.L., Holmes A. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res 2006, 170:126-140.
51. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J.A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 1998, 43:547-573.
52. Hatsukami D.K., Grillo M., Pentel P.R., Oncken C., Bliss R. Safety of cotinine in humans: physiologic, subjective, and cognitive effects. Pharmacol Biochem Behav 1997, 57:643-650.